Should criteria for inclusion in cancer clinical trials be expanded?

Journal of Comparative Effectiveness Research

Volumn 4, Issue 4, 2015, Pages 289-291

  Gerber, David E ^a   Pruitt, Sandi L ^b   Halm, Ethan A ^b,c,d  

^a Division of Hematology Oncology   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Department of Clinical Sciences ^*  (United States)

^d Internal Medicine   (United States)

Author keywords

accrual; cancer; clinical trials; eligibility; enrollment; exclusion criteria

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL STUDY; COMPARATIVE EFFECTIVENESS; EDITORIAL; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH CARE COST; HUMAN; INTERNAL VALIDITY; JOURNAL IMPACT FACTOR; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MEDICAL SERVICE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; CLINICAL TRIAL (TOPIC); NEOPLASMS; PATIENT SELECTION;

CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; PATIENT SELECTION;

EID: 84939428356     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer.15.27     Document Type: Editorial

References (14)

1. Lemieux J, Goodwin PJ, Pritchard KI et al. Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials. J. Clin. Oncol. 26, 4458-4465 (2008).
2. McCusker J, Wax A, Bennett JM. Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry. Am. J. Clin. Oncol. 5, 227-236 (1982).
3. Kotwall CA, Mahoney LJ, Myers RE et al. Reasons for nonentry in randomized clinical trials for breast cancer: a single institutional study. J. Surg. Oncol. 50, 125-129 (1992).
4. Fuks A, Weijer C, Freedman B et al. A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. J. Clin. Epidemiol. 51, 69-79 (1998).
5. Begg CB, Engstrom PF. Eligibility and extrapolation in cancer clinical trials. J. Clin. Oncol. 5, 962-968 (1987).
6. Masoudi FA, Havranek EP, Wolfe P et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am. Heart. J. 146, 250-257 (2003).
7. Van Spall HG, Toren A, Kiss A et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297, 1233-1240 (2007).
8. Gerber DE, Laccetti AL, Xuan L et al. Impact of prior cancer on eligibility for lung cancer clinical trials. J. Natl Cancer Inst. 106(11), dju302 (2014).
9. Laccetti AL, Pruitt SL, Xuan L et al. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual. J. Natl Cancer Inst. 107(4), djv002 (2015).
10. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291, 2720-2726 (2004).
11. Friedman MA, Cain DF. National Cancer Institute sponsored cooperative clinical trials. Cancer 65, 2376-2382 (1990).
12. Lara PN Jr, Higdon R, Lim N et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J. Clin. Oncol. 19, 1728-1733 (2001).
13. Ross S, Grant A, Counsell C et al. Barriers to participation in randomised controlled trials: a systematic review. J. Clin. Epidemiol. 52, 1143-1156 (1999).
14. Howerton MW, Gibbons MC, Baffi CR et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109, 465-476 (2007).